Parabilis Medicines, Inc.

Research Parabilis Medicines, Inc. (PBLS) on Bullrun: market cap USD 3.16B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPBLS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.16B
• Financial periodQ1 2026
• Net income-USD 45.32M
• Free cash flow-USD 49.57M

Valuation Snapshot

latest market cap is USD 3.16B.

About Parabilis Medicines, Inc.

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable.

Frequently asked questions

What is Parabilis Medicines, Inc.'s market cap?

Parabilis Medicines, Inc.'s market capitalization is USD 3.16B.

What does Parabilis Medicines, Inc. do?

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.